FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W9904803> ?p ?o ?g. }

• W9904803 endingPage "146" @default.
• W9904803 startingPage "146" @default.
• W9904803 abstract "The Review of Diabetic Studies,2005,2,3,146-156.DOI:10.1900/RDS.2005.2.146Published:November 2005Type:Original ArticleAuthors:Wageh M Awara, Alaa E El-Sisi, Mohamed El-Refaei, Mona M El-Naa, and Karima El-Desoky Author(s) affiliations:Wageh M. Awara1, Alaa E. El-Sisi1, Mohamed El-Refaei2, Mona M. El-Naa1, Karima El-Desoky3 1Department of Pharmacology/Toxicology, College of Pharmacy, University of Tanta, Egypt. 2Department of Biochemistry, Genetic Engineering and Biotechnology Research Institute, Minofia University, Egypt. 3Department of Pathology, Faculty of Medicine, University of Tanta, Egypt. Abstract:Cytokines and nitric oxide (NO) are involved in the pathogenesis of autoimmune diabetes mellitus (DM). Rosiglitazone is an insulin-sensitizing drug that is a ligand for the nuclear receptor peroxisome proliferator-activated receptorgamma (PPAR-γ). The anti-inflammatory and immunomodulating properties of PPAR-γ have been documented. The aim of this study is to investigate the effectiveness of rosiglitazone in autoimmune DM and to clarify the possible mechanism(s) involved. Autoimmune DM was induced in adult male Balb/c mice by co-administration of cyclosporin A and multiple low doses of streptozotocin. Diabetic mice were treated daily with rosiglitazone (7 mg/kg, p.o.) for 21 days. Blood glucose level (BGL), serum insulin level and pancreatic levels of tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ) and NO were measured. Histopathological examination and immunohistochemical determination of CD4 and CD8 T lymphocytes in the pancreatic islets were performed. In addition, analysis of pancreatic protein expression was carried out. The results showed that rosiglitazone treatment resulted in a significant decrease in the BGL and the pancreatic levels of TNF-α, IFN-γ and NO compared to diabetic mice. The serum insulin level was significantly increased after rosiglitazone treatment compared to diabetic mice. The destroyed pancreatic islets were regenerated and became free from both CD4 and CD8 T cells after treatment. Furthermore, many changes in pancreatic protein expression were observed. These results suggest that rosiglitazone has a beneficial effect in the treatment of autoimmune diabetes, an effect that seemed to be a secondary consequence of its anti-inflammatory and immunomodulating properties and might be reflected at the level of protein expression. Keywords:Autoimmune diabetes, Cytokines, Insulitis, Mltiple low doses of streptozotocin, Nitric oxide, PPAR-γ, Rosiglitazone, ThiazolidinedioneView:PDF (540.37 KB)" @default.
• W9904803 created "2016-06-24" @default.
• W9904803 creator A5015818706 @default.
• W9904803 creator A5022174155 @default.
• W9904803 creator A5046388388 @default.
• W9904803 creator A5071496821 @default.
• W9904803 creator A5076124905 @default.
• W9904803 date "2005-01-01" @default.
• W9904803 modified "2023-09-26" @default.
• W9904803 title "Insulinotropic and Anti-Inflammatory Effects of Rosiglitazone in Experimental Autoimmune Diabetes" @default.
• W9904803 cites W1499727701 @default.
• W9904803 cites W1505646153 @default.
• W9904803 cites W1565885233 @default.
• W9904803 cites W1608005125 @default.
• W9904803 cites W1656371604 @default.
• W9904803 cites W1960601565 @default.
• W9904803 cites W1963764925 @default.
• W9904803 cites W1965026439 @default.
• W9904803 cites W1970565798 @default.
• W9904803 cites W1986507932 @default.
• W9904803 cites W1997608954 @default.
• W9904803 cites W2001632177 @default.
• W9904803 cites W2004278043 @default.
• W9904803 cites W2006904161 @default.
• W9904803 cites W2009890609 @default.
• W9904803 cites W2010357177 @default.
• W9904803 cites W2011801069 @default.
• W9904803 cites W2015767988 @default.
• W9904803 cites W2018289835 @default.
• W9904803 cites W2019235722 @default.
• W9904803 cites W2019570781 @default.
• W9904803 cites W2020060493 @default.
• W9904803 cites W2022048961 @default.
• W9904803 cites W2023459898 @default.
• W9904803 cites W2033056749 @default.
• W9904803 cites W2033375159 @default.
• W9904803 cites W2036594829 @default.
• W9904803 cites W2036688779 @default.
• W9904803 cites W2037738045 @default.
• W9904803 cites W2046564708 @default.
• W9904803 cites W2050954221 @default.
• W9904803 cites W2054602020 @default.
• W9904803 cites W2056647549 @default.
• W9904803 cites W2059895383 @default.
• W9904803 cites W2063657505 @default.
• W9904803 cites W2075503219 @default.
• W9904803 cites W2078567778 @default.
• W9904803 cites W2080153394 @default.
• W9904803 cites W2080889198 @default.
• W9904803 cites W2088400959 @default.
• W9904803 cites W2088477504 @default.
• W9904803 cites W2100837269 @default.
• W9904803 cites W2103314962 @default.
• W9904803 cites W2104224178 @default.
• W9904803 cites W2114276605 @default.
• W9904803 cites W2119127358 @default.
• W9904803 cites W2120337054 @default.
• W9904803 cites W2121524949 @default.
• W9904803 cites W2128851263 @default.
• W9904803 cites W2132915524 @default.
• W9904803 cites W2142219287 @default.
• W9904803 cites W2153124183 @default.
• W9904803 cites W2157393124 @default.
• W9904803 cites W2158179799 @default.
• W9904803 cites W2158969881 @default.
• W9904803 cites W2170651583 @default.
• W9904803 cites W33560825 @default.
• W9904803 doi "https://doi.org/10.1900/rds.2005.2.146" @default.
• W9904803 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1783562" @default.
• W9904803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17491689" @default.
• W9904803 hasPublicationYear "2005" @default.
• W9904803 type Work @default.
• W9904803 sameAs 9904803 @default.
• W9904803 citedByCount "9" @default.
• W9904803 countsByYear W99048032012 @default.
• W9904803 countsByYear W99048032013 @default.
• W9904803 countsByYear W99048032015 @default.
• W9904803 countsByYear W99048032016 @default.
• W9904803 crossrefType "journal-article" @default.
• W9904803 hasAuthorship W9904803A5015818706 @default.
• W9904803 hasAuthorship W9904803A5022174155 @default.
• W9904803 hasAuthorship W9904803A5046388388 @default.
• W9904803 hasAuthorship W9904803A5071496821 @default.
• W9904803 hasAuthorship W9904803A5076124905 @default.
• W9904803 hasBestOaLocation W99048031 @default.
• W9904803 hasConcept C126322002 @default.
• W9904803 hasConcept C134018914 @default.
• W9904803 hasConcept C170493617 @default.
• W9904803 hasConcept C17991360 @default.
• W9904803 hasConcept C187345961 @default.
• W9904803 hasConcept C203014093 @default.
• W9904803 hasConcept C2779280383 @default.
• W9904803 hasConcept C2779306644 @default.
• W9904803 hasConcept C2780130043 @default.
• W9904803 hasConcept C2780152017 @default.
• W9904803 hasConcept C519581460 @default.
• W9904803 hasConcept C555293320 @default.
• W9904803 hasConcept C71924100 @default.

• next